trending Market Intelligence /marketintelligence/en/news-insights/trending/6uYynv_UfBFF4I47uF2pOQ2 content esgSubNav
In This List

Knight Therapeutics raises over C$100M in bought-deal offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Knight Therapeutics raises over C$100M in bought-deal offering

Knight Therapeutics Inc. raised C$100.1 million in a bought-deal offering of shares led by GMP Securities LP and Cormark Securities Inc.

The company issued 10,005,000 common shares at C$10 apiece, including 1,305,000 securities that were issued as part of a fully exercised overallotment option.

Knight Therapeutics will use amounts raised to fund future growth and for general corporate purposes.

Bloom Burton & Co. Ltd., CIBC World Markets Inc., Laurentian Bank Securities Inc., Mackie Research Capital Corp., National Bank Financial Inc., Paradigm Capital Inc., Scotia Capital Inc. and TD Securities Inc. also participated in the offering.